Industry news

First Russian intradermal implant obtained registration

GMP News

The first Russian intradermal implant has successfully passed the state registration. This product has been developed over the past three years with the support of the Russian Ministry of Industry and Trade as part of the state policy of import substitution.

EEC changed rules for registration of vaccines and use of GMP certificates

GMP News

The Council of the Eurasian Economic Commission (EEC) has amended the rules for registration and expert examination of medicinal products for human use in the Eurasian Economic Union. In particular, it adopted common approaches to the procedure for changing the registration documents for flu prevention vaccines.

19 June 2018

Marinus Pharmaceuticals Initiates Pivotal Phase 3 Trial in Children with CDKL5 Deficiency Disorder

Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (“Marinus” or “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced the initiation of a pivotal Phase 3 clinical trial (Marigold Study) evaluating the use of oral ganaxolone in children and young adults with CDKL5 Deficiency Disorder (CDD).

Russia is ready to supply insulin to Bulgaria

GMP News

“The time has come to reduce imports from abroad and start establishing contacts with neighbors,” said Ivan Zarubin, acting Trade Representative of the Russian Federation in the Republic of Bulgaria, speaking at the Medicine and Pharmacy 2018, a Bulgarian-Russian business forum held in Sofia on June 13.

Construction of a new pharmaceutical plant started in Usolye-Sibirskoye

GMP News

An official ceremony marking the launch of construction was held at the site of future plant for active pharmaceutical substances and finished medicinal products of Pharmasyntez-Chemie in Usolye-Sibirskoye on June 15.

The cost of drug labeling implementation is considered as reasonable

GMP News

According to market participants, the costs of drug manufacturers on mandatory implementation of labeling by 2020 will not increase the cost of drugs. “We do not expect that the cost of medicinal products manufactured by Stada will rise following the implementation of drug labeling,” said Ivan Glushkov, Director of External Relations Department at Stada Russia.

Russian nationwide network of biobanks will help to develop new drugs

GMP News

New drugs and treatments development requires experiments on animals and humans. However, many problems can be solved just by studying the samples of human tissues outside the human body. To this end, Russia is establishing a nationwide network of biobanks.

15 June 2018

Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)

Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced that the Compensation Committee of the Board of Directors of Marinus granted non-qualified stock options to purchase an aggregate of 90,000 shares of its common stock to two new employees, with a grant date of  June 14, 2018 .

New Russian Cancer Drug Increases Survival Rate of Mice by Over 50%

Remedium

A group of researchers from the National University of Science and Technology MISIS (NUST MISIS) and the Pirogov Russian National Research Medical University have conducted preclinical studies of a new cancer drug based on magnetic nanoparticles.

Indian company wants to build a pharmaceutical plant in Kursk

GMP News

On June 9, 15 new contracts and agreements were signed as part of the business program of the Kursk Korenskaya Fair. One of the signed documents was the memorandum of understanding on cooperation between the city of Kursk and ZEE Laboratories Ltd., an Indian pharmaceutical company.